Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262867 · ClinicalTrials.gov registry record · NA
Early Allergen System Experience
A NA study of Food Allergy in Infants, sponsored by Prollergy dba Ready Set Food.
- Active
- Registry status
- NA
- Development phase
- 1,110
- Enrollment target
- 1
- Study location
NCT06262867: Active NA study of Food Allergy in Infants, sponsored by Prollergy dba Ready Set Food.
NCT06262867 is a NA study of Food Allergy in Infants that is active but no longer recruiting, run by Prollergy dba Ready Set Food. The registered enrollment target is 1,110 participants, below the 4,758-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06262867, a NA study of Food Allergy in Infants, is active but no longer recruiting, sponsored by Prollergy dba Ready Set Food.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,110 participants
- Enrollment target
- 1
- Study location
Study Summary
Multiple clinical trials have demonstrated that early allergen introduction, feeding babies common food allergens before six months, decreases children's risk of developing a food allergy. Despite successful food allergy introduction trials showing that food allergies can be prevented, early introduction in the required amount can be challenging for parents. In some studies, less than 20% of parents introduce peanuts before their child is six months old, and few feed them regularly after introduction. Ready. Set. Food! is a direct-to-consumer product that offers a convenient supplement with a daily dose regimen that can be added to breastmilk, formula, or food to make early allergen introduction easy. The formulation includes cow's milk, egg, and peanut, representing the majority of childhood food allergies, and the protein levels are based on doses found to be effective in clinical trials. Over 200,000 infants have used Ready. Set. Food!. This study investigates the effectiveness of introducing common allergens to infants with the goal of preventing food allergies. The study will enroll 1,100 infants stratified by their risk of developing a food allergy who are assigned to either receive Ready. Set. Food! supplements or follow standard allergen introduction practices recommended by their pediatrician. The goal of this study is to assess how Ready. Set. Food! allergen introduction supplements improve the experience of parents introducing allergens, decrease healthcare costs related to food allergies, and decrease food allergy prevalence.
Primary Outcome
Adherence will be measured using a food frequency questionnaire
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ready. Set. Food! Stage 1 Mix ins
Study Locations (1)
New York
- Virtual Site Location - Curavit - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,110 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT06262867 still lists
NCT06262867 is an interventional study that assigns participants to a tested intervention. Its 1,110 participants enrollment target places it among the larger protocols in the corpus, below the 4,758-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Food Allergy in Infants appearing as the primary indexed condition, and to 1 intervention - of which Ready. Set. Food! Stage 1 Mix ins is the first listed.
NCT06262867 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06262867 about?
NCT06262867 is a clinical study titled "Early Allergen System Experience". Multiple clinical trials have demonstrated that early allergen introduction, feeding babies common food allergens before six months, decreases children's risk of developing a food allergy. Despite successful food allergy introduction trials showing that food allergies can be prevented, early introdu...
What is the current status of trial NCT06262867?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,110 participants. The study started on 2024-03-07. Estimated completion is 2026-07-01.
What conditions does trial NCT06262867 study?
This clinical trial studies the following conditions: Food Allergy in Infants.
What interventions are being tested in trial NCT06262867?
The interventions under investigation include: Ready. Set. Food! Stage 1 Mix ins (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06262867?
This trial is sponsored by Prollergy dba Ready Set Food, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262867 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Allergy in Infants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
RECRUITING · NA
-
Intervention to Reduce Early (Peanut) Allergy in Children
ACTIVE NOT RECRUITING · NA
-
Investigating the Detection of Bovine and Soy Proteins in Human Milk
COMPLETED · NA
-
A Registry for the Food Allergy Community
RECRUITING
-
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI